BVCF Leads Series A Round For Shanghai Drug Maker CARsgen

This Data Is Locked!

This area is available only to Subscribers.

Shanghai-based immunotherapy firm CARsgen says it has completed an undisclosed amount of series A financing led by Shanghai-based BVCF, a growth capital-focused private equity fund... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?